Race Oncology Soars 23% on Breakthrough Discovery Targeting MYC
Race Oncology (ASX: RAC) opened strongly, rising 23 percent after releasing new insights into how its lead cancer drug, bisantrene…
02
the Kick-ass Multipurpose WordPress Theme
